We are live on ! Find out more
SM

SG3 Management Portfolio holdings

AUM $6.45K
1-Year Est. Return 61.81%
This Fund
S&P 500
This Quarter Est. Return
+12.91%
1 Year Est. Return
-61.81%
3 Year Est. Return
-38.3%
5 Year Est. Return
-6.2%
10 Year Est. Return
AUM
$4.92B
AUM Growth
+$1.62B
Cap. Flow
+$1.41B
Cap. Flow %
28.67%
Top 10 Hldgs %
36.75%
Holding
1,419
New
468
Increased
176
Reduced
163
Closed
410

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$208M
2
AMZN icon
Amazon
AMZN
+$165M
3
AMD icon
Advanced Micro Devices
AMD
+$86.9M
4
XYZ
Block Inc
XYZ
+$33.2M
5
ROKU icon
Roku
ROKU
+$27M

Top Sells

Rank Stock Value
1
XLRN
Acceleron Pharma
XLRN
+$10.3M
2
MRNA icon
Moderna
MRNA
+$9.79M
3
JD icon
JD.com
JD
+$6.14M
4
AZN icon
AstraZeneca
AZN
+$5.27M
5
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$4.32M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 8.5%
2 Technology 4.33%
3 Communication Services 2.49%
4 Healthcare 1.87%
5 Financials 0.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EVGO icon
976
EVgo
EVGO
$219M
$30K ﹤0.01%
+3,000
New +$32.8K
UWMC icon
977
PUT
UWM Holdings
UWMC
$672M
$30K ﹤0.01%
+5,000
New +$33.7K
CCO icon
978
CALL
Clear Channel Outdoor Holdings
CCO
$1.22B
$29K ﹤0.01%
+8,800
New +$27.4K
BLU
979
PUT
DELISTED
BELLUS Health Inc.
BLU
$29K ﹤0.01%
+3,600
New +$23.9K
ONCS
980
CALL
DELISTED
OncoSec Medical Incorporated
ONCS
$29K ﹤0.01%
1,364
+455
+50% +$15.4K
AMRN
981
CALL
Amarin Corp
AMRN
$297M
$28K ﹤0.01%
415
CZR icon
982
PUT
Caesars Entertainment
CZR
$6.06B
$28K ﹤0.01%
300
ORGO icon
983
PUT
Organogenesis Holdings
ORGO
$324M
$28K ﹤0.01%
+3,000
New +$31.9K
AMRN
984
Amarin Corp
AMRN
$297M
$27K ﹤0.01%
394
STNG icon
985
CALL
Scorpio Tankers
STNG
$3.91B
$27K ﹤0.01%
+2,100
New +$32.4K
LOW icon
986
CALL
Lowe's Companies
LOW
$121B
$26K ﹤0.01%
+100
New +$23.8K
PWP icon
987
PUT
Perella Weinberg Partners
PWP
$1.08B
$26K ﹤0.01%
2,000
-14,000
-88% -$184K
MRIN
988
DELISTED
Marin Software
MRIN
$24K ﹤0.01%
+1,083
New +$38.5K
ANNX icon
989
Annexon
ANNX
$796M
$23K ﹤0.01%
+2,000
New +$32.3K
CMPS
990
Compass Pathways
CMPS
$1.47B
$23K ﹤0.01%
+1,032
New +$32.8K
PLUR icon
991
CALL
Pluri
PLUR
$17M
$21K ﹤0.01%
1,775
TMC icon
992
CALL
TMC The Metals Company
TMC
$1.49B
$21K ﹤0.01%
10,000
-20,000
-67% -$60.6K
UUUU icon
993
Energy Fuels
UUUU
$2.68B
$20K ﹤0.01%
+2,600
New +$22K
CABA icon
994
CALL
Cabaletta Bio
CABA
$427M
$19K ﹤0.01%
+5,100
New +$54.4K
CTSH icon
995
CALL
Cognizant
CTSH
$26.5B
$18K ﹤0.01%
+200
New +$16.1K
BDSI
996
CALL
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$18K ﹤0.01%
5,700
-19,100
-77% -$64.3K
BYSI icon
997
PUT
BeyondSpring
BYSI
$47.3M
$16K ﹤0.01%
3,600
-1,800
-33% -$20.3K
XOS icon
998
Xos
XOS
$26.8M
$16K ﹤0.01%
+167
New +$20.6K
VFC icon
999
CALL
VF Corp
VFC
$5.92B
$15K ﹤0.01%
+200
New +$14.6K
CLVS
1000
CALL
DELISTED
Clovis Oncology, Inc.
CLVS
$14K ﹤0.01%
5,000

Similar funds

SG3 Management's Q4 2021 Portfolio in Review

As of Q4 2021, SG3 Management held 1,419 positions worth $4.92B, up 49% from $3.3B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

SG3 Management deployed $1.41B of net new capital in Q4 2021, opening 468 new positions and adding to 176 existing holdings. Its largest new stake was Tesla: 619,500 shares worth $218M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 8.5% of assets, up from 0.74% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Moderna, an estimated $9.79M trimmed.

  • SG3 Management's largest Q4 2021 buy was Tesla: 619,500 shares worth $218M.
  • SG3 Management added most to Amazon in Q4 2021, an estimated $165M increase.
  • SG3 Management's biggest Q4 2021 reduction was Moderna, cutting an estimated $9.79M.
  • SG3 Management fully exited Acceleron Pharma in Q4 2021, selling an estimated $10.3M.
  • SG3 Management's ten largest holdings make up 37% of its $4.92B portfolio in Q4 2021.
  • SG3 Management opened 468 new positions and closed 410 in Q4 2021.
  • SG3 Management's portfolio value rose 49% quarter-over-quarter to $4.92B.

Based on SG3 Management's 13F filing for Q4 2021, filed 15 Feb 2022.